BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20408563)

  • 1. QSAR modeling and prediction of the endocrine-disrupting potencies of brominated flame retardants.
    Papa E; Kovarich S; Gramatica P
    Chem Res Toxicol; 2010 May; 23(5):946-54. PubMed ID: 20408563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR classification models for the prediction of endocrine disrupting activity of brominated flame retardants.
    Kovarich S; Papa E; Gramatica P
    J Hazard Mater; 2011 Jun; 190(1-3):106-12. PubMed ID: 21454014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the endocrine disrupting effects of brominated flame retardants.
    Legler J
    Chemosphere; 2008 Sep; 73(2):216-22. PubMed ID: 18667224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are brominated flame retardants endocrine disruptors?
    Legler J; Brouwer A
    Environ Int; 2003 Sep; 29(6):879-85. PubMed ID: 12850103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants.
    Hamers T; Kamstra JH; Sonneveld E; Murk AJ; Kester MH; Andersson PL; Legler J; Brouwer A
    Toxicol Sci; 2006 Jul; 92(1):157-73. PubMed ID: 16601080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR classification models for the screening of the endocrine-disrupting activity of perfluorinated compounds.
    Kovarich S; Papa E; Li J; Gramatica P
    SAR QSAR Environ Res; 2012; 23(3-4):207-20. PubMed ID: 22352429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal activities of new brominated flame retardants.
    Ezechiáš M; Svobodová K; Cajthaml T
    Chemosphere; 2012 May; 87(7):820-4. PubMed ID: 22236593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAR and QSAR modeling of endocrine disruptors.
    Devillers J; Marchand-Geneste N; Carpy A; Porcher JM
    SAR QSAR Environ Res; 2006 Aug; 17(4):393-412. PubMed ID: 16920661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR prediction of the competitive interaction of emerging halogenated pollutants with human transthyretin.
    Papa E; Kovarich S; Gramatica P
    SAR QSAR Environ Res; 2013; 24(4):333-49. PubMed ID: 23710908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles.
    Liu H; Papa E; Gramatica P
    Chem Res Toxicol; 2006 Nov; 19(11):1540-8. PubMed ID: 17112243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear QSAR regression models for the prediction of bioconcentration factors by physicochemical properties and structural theoretical molecular descriptors.
    Papa E; Dearden JC; Gramatica P
    Chemosphere; 2007 Feb; 67(2):351-8. PubMed ID: 17109926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-activity relationship modeling on in vitro endocrine effects and metabolic stability involving 26 selected brominated flame retardants.
    Harju M; Hamers T; Kamstra JH; Sonneveld E; Boon JP; Tysklind M; Andersson PL
    Environ Toxicol Chem; 2007 Apr; 26(4):816-26. PubMed ID: 17447568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistically validated QSARs, based on theoretical descriptors, for modeling aquatic toxicity of organic chemicals in Pimephales promelas (fathead minnow).
    Papa E; Villa F; Gramatica P
    J Chem Inf Model; 2005; 45(5):1256-66. PubMed ID: 16180902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and QSAR modeling on multiple endpoints of estrogen activity based on different bioassays.
    Liu H; Papa E; Gramatica P
    Chemosphere; 2008 Feb; 70(10):1889-97. PubMed ID: 17884132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of toxicity and data exploratory analysis of estrogen-active endocrine disruptors using counter-propagation artificial neural networks.
    Stojić N; Erić S; Kuzmanovski I
    J Mol Graph Model; 2010 Nov; 29(3):450-60. PubMed ID: 20952233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico screening of estrogen-like chemicals based on different nonlinear classification models.
    Liu H; Papa E; Walker JD; Gramatica P
    J Mol Graph Model; 2007 Jul; 26(1):135-44. PubMed ID: 17293141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic effects of brominated flame retardants in man and in wildlife.
    Darnerud PO
    Environ Int; 2003 Sep; 29(6):841-53. PubMed ID: 12850100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of commercially used brominated flame retardants, their applications, their use patterns in different countries/regions and possible modes of release.
    Alaee M; Arias P; Sjödin A; Bergman A
    Environ Int; 2003 Sep; 29(6):683-9. PubMed ID: 12850087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine disruptors and thyroid hormone physiology.
    Jugan ML; Levi Y; Blondeau JP
    Biochem Pharmacol; 2010 Apr; 79(7):939-47. PubMed ID: 19913515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binary classification models for endocrine disrupter effects mediated through the estrogen receptor.
    Roncaglioni A; Piclin N; Pintore M; Benfenati E
    SAR QSAR Environ Res; 2008; 19(7-8):697-733. PubMed ID: 19061085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.